Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver

NCT03069950 PHASE2 WITHDRAWN

The purpose of this study is to see if patients treated with both regional chemotherapy using the HAI pump and intravenous chemotherapy are able to have their liver tumors removed surgically (resected), versus treatment with only intravenous chemotherapy.

Details

Lead sponsor	Memorial Sloan Kettering Cancer Center
Phase	PHASE2
Status	WITHDRAWN
Start date	Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu May 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Colorectal Adenocarcinoma Metastatic to the Liver

Interventions

• Floxuridine (FUDR)
• Irinotecan (CPT-11)
• FLUOROURACIL
• PANITUMUMAB
• DEXAMETHASONE
• Leucovorin

Countries

United States